866-997-4948(US-Canada Toll Free)

Contraceptives Market to 2016 - Demand for Long Acting Birth Control Pills Encourages Growth in Hormonal Contraceptives Market

Published By :

GBI Research

Published Date : Dec 2010

Category :

Therapeutic Area

No. of Pages : 97 Pages


GBI Research, the leading business intelligence provider, has released its latest research “Contraceptives Market to 2016 - Demand for Long Acting Birth Control Pills Encourages Growth in Hormonal Contraceptives Market” which provides insight about contraceptive sales and price forecasts until 2016. 

The report also delves deep into global contraceptive treatment usage patterns. Further, contraceptive markets in the key geographies of the US, top five EU countries and Japan are also covered in the report. The report also includes details about contraceptive R&D pipelines and potential future blockbuster products. The report provides in-depth analysis of the main contraceptive classes, which includes oral contraceptives, injectables and topical contraceptives. 

Furthermore, it includes market forecasts and treatment usage patterns for each therapeutic class. The report also explores the competitive landscape, with a competitive analysis of the top companies in the market. Finally, a key trend analysis of mergers and acquisitions, and licensing agreements in the contraceptives market is also included. 

Scope

The scope of this report includes:

  • Data and analysis of the contraceptives market in the leading geographies which includes the US, the UK, Germany, France, Italy, Spain, and Japan.
  • Annualized market data for the contraceptives market from 2001 to 2009, with forecasts to 2016.
  • Market data on the geographical landscape and therapeutic landscape, including market sizes, market shares, annual costs of therapy, sales volumes and treatment usage patterns, such as disease populations, treatment seeking populations, diagnosis populations and prescription populations.
  • Key drivers and restraints that have had significant impact on the market.
  • Competitive landscape of the global contraceptives market including benchmarking of the top companies. The key companies studied in this report are Merck/Schering-Plough, Pfizer/Wyeth, Johnson and Johnson, Bayer and Warner Chilcott
  • Key M&A and licensing agreements that have taken place between 2008 and 2009 in the contraceptives market
Reasons to buy

The report will aid business development and help marketing executives strategizing product launches:

  • Build effective strategies to launch pipeline products, by identifying potential geographies.
  • Exploit in-licensing and out-licensing opportunities by identifying products to fill their portfolio gaps.
  • Develop key strategic initiatives by studying the key strategies of the top competitors.
  • Develop market-entry and market expansion strategies, by identifying the geographic markets poised for strong growth.
  • Reinforce R&D pipelines by identifying new target mechanisms which can produce first in class molecules with more efficiency and better safety.
Table of Contents

1 Table of Contents 3

1.1 List of Tables 5
1.2 List of Figures 7

2 Global Contraceptives Market: Introduction 9
2.1 GBI Research Report Guidance 9

3 Global Contraceptives Market: Market Overview 10
3.1 Introduction 10
3.1.1 Drivers and Barriers 11
3.1.2 Opportunity and Unmet Need 11

4 Global Contraceptives Market: Market Characterization 12
4.1 Revenue 12
4.2 Annual Cost of Treatment 13
4.3 Treatment Usage Patterns 14
4.3.1 Target Population 16
4.3.2 Treatment Seeking Population 17
4.3.3 Population Taking Prescribed Contraceptive Drugs 18
4.3.4 Population Taking OTC Contraceptive Drugs 19

5 Global Contraceptives Market: Geographical Landscape 20
5.1 Revenue Analysis by Geography 20
5.2 The US 20
5.2.1 Revenue 20
5.2.2 Annual Cost of Treatment 22
5.2.3 Treatment Usage Patterns 23
5.3 Top Five Countries of Europe 29
5.3.1 Revenue 29
5.3.2 Annual Cost of Treatment 30
5.3.3 Treatment Usage Patterns 31
5.4 Japan 37
5.4.1 Revenue 37
5.4.2 Annual Cost of Treatment 38
5.4.3 Treatment Usage Patterns 39

6 Global Contraceptives Market: Therapeutic Landscape 45
6.1 Oral Contraceptives Market 45
6.1.1 Revenue 45
6.1.2 Annual Cost of Treatment 46
6.1.3 Treatment Usage Patterns 47
6.2 Injectables Market 53
6.2.1 Revenue 53
6.2.2 Annual Cost of Treatment 54
6.2.3 Treatment Usage Patterns 55
6.3 Topical Contraceptives Market 61
6.3.1 Revenue 61
6.3.2 Annual Cost of Treatment 62
6.3.3 Treatment Usage Patterns 63

7 Global Contraceptives Market: Pipeline Analysis 69
7.1 Introduction 69
7.2 Profiles of Promising Drugs in the Contraceptive Market 72
7.2.1 AG200-15 72
7.2.2 Yaz Flex 72
7.2.3 Pill Plus 73

8 Global Contraceptives Market: Competitive Landscape 74
8.1 Evolving competitive landscape 74
8.2 Market Share Analysis 75
8.2.1 Major Players 76
8.3 Competitive Profiling 77
8.3.1 Pfizer 77
8.3.2 Watson 78
8.3.3 Teva Pharmaceuticals 80
8.3.4 Warner Chilcott Ltd. 81
8.3.5 Johnson & Johnson 83
8.3.6 Bayer AG 84
8.3.7 The National Institute of Allergy and Infectious Diseases 86

9 Global Contraceptives Market: M&A Landscape 87

9.1 Overview 87
9.1.1 M&A Deals by Value ($) 87
9.2 R&D Licensing Agreements 89
9.2.1 Deals by Phase 89
9.2.2 Deals by Geography 90
9.2.3 Phase I 90
9.2.4 Phase II 91
9.2.5 Phase III 91
9.2.6 Marketed Drugs 92

10 Global Contraceptives Market: Appendix 93
10.1 Market Definitions 93
10.2 Abbreviations 93
10.3 Research Methodology 93
10.3.1 Coverage 93
10.3.2 Secondary Research 94
10.3.3 Primary Research 94
10.3.4 Forecasts 94
10.3.5 Expert Panel Validation 97
10.4 Contact Us 97
10.5 Disclaimer 97
10.6 Sources 97

List of Table


Table 1: Global Contraceptives Market, Revenue ($bn), 2001-2009
Table 2: Global Contraceptives Market, Revenue Forecasts ($bn), 2009-2016
Table 3: Global Contraceptives Market, Annual Cost of Treatment - Prescribed Drugs ($), 2001-2009
Table 4: Global Contraceptives Market, Annual Cost of Treatment - Prescribed Drugs ($), 2009-2016
Table 5: Global Contraceptives Market, Treatment Usage Patterns (000’s), 2001-2009
Table 6: Global Contraceptives Market, Treatment Usage Patterns (000’s), 2009-2016
Table 7: The US Contraceptives Market, Revenue ($bn), 2001-2009
Table 8: The US Contraceptives Market, Revenue Forecasts ($bn), 2009-2016
Table 9: The US Contraceptives Market, Annual Cost of Treatment ($), 2001-2009
Table 10: The US Contraceptives Market, Annual Cost of Treatment ($), 2009-2016
Table 11: The US Contraceptives Market, Treatment Usage Patterns (000’s), 2001-2009
Table 12: The US Contraceptives Market, Treatment Usage Patterns (000’s), 2009-2016
Table 13: Top Five Countries of Europe Contraceptives Market, Revenue ($m), 2001-2009
Table 14: Top Five Countries of Europe Contraceptives Market, Revenue Forecasts ($m), 2009-2016
Table 15: Top Five Countries of Europe Contraceptives Market, Annual Cost of Treatment ($), 2001-2009
Table 16: Top Five Countries of Europe Contraceptives Market, Annual Cost of Treatment ($), 2009-2016
Table 17: Top Five Countries of Europe Contraceptives Market, Treatment Usage Patterns (000’s), 2001-2009
Table 18: Top Five Countries of Europe Contraceptives Market, Treatment Usage Patterns (000’s), 2009-2016
Table 19: Japan Contraceptives Market, Revenue ($m), 2001-2009
Table 20: Japan Contraceptives Market, Revenue Forecasts ($m), 2009-2016
Table 21: Japan Contraceptives Market, Annual Cost of Treatment ($), 2001-2009
Table 22: Japan Contraceptives Market, Annual Cost of Treatment ($), 2009-2016
Table 23: Contraceptives Market , Japan, Treatment Usage Patterns (000’s), 2001-2009
Table 24: Japan Contraceptives Market, Treatment Usage Patterns (000’s), 2009-2016
Table 25: Global Oral Contraceptives Market, Revenue ($bn), 2001-2009
Table 26: Global Oral Contraceptives Market, Revenue Forecasts ($bn), 2009-2016
Table 27: Global Oral Contraceptives Market, Annual Cost of Treatment ($), 2001-2009
Table 28: Global Oral Contraceptives Market, Annual Cost of Treatment ($), 2009-2016
Table 29: Global Oral Contraceptives Market, Treatment Usage Patterns (000’s), 2001-2009
Table 30: Global Oral Contraceptives Market, Treatment Usage Patterns (000’s), 2009-2016
Table 31: Global Injectables Market, Revenue ($m), 2001-2009
Table 32: Global Injectables Market, Revenue Forecasts ($m), 2009-2016
Table 33: Global Injectables Market, Annual Cost of Treatment ($), 2001-2009
Table 34: Global Injectables Market, Annual Cost of Treatment ($), 2009-2016
Table 35: Global Injectables Market, Treatment Usage Patterns (000’s), 2001-2009
Table 36: Global Injectables Market, Treatment Usage Patterns (000’s), 2009-2016
Table 37: Global Topical Contraceptives Market, Revenue ($m), 2001-2009
Table 38: Global Topical Contraceptives Market, Revenue Forecasts ($m), 2009-2016
Table 39: Global Topical Contraceptives Market, Annual Cost of Treatment - Prescribed Drugs ($), 2001-2009
Table 40: Global Topical Contraceptives Market, Annual Cost of Treatment - Prescribed Drugs ($), 2009-2016
Table 41: Global Topical Contraceptives Market, Treatment Usage Patterns (000’s), 2001-2009
Table 42: Global Topical Contraceptives Market, Treatment Usage Patterns (000’s), 2009-2016
Table 43: Contraceptives Pipeline, Pre Clinical Molecules, 2010
Table 44: Contraceptives Pipeline, Phase I Molecules, 2010
Table 45: Contraceptives Pipeline, Phase II Molecules, 2010
Table 46: Contraceptives Pipeline, Phase III Molecules, 2010
Table 47: Contraceptives Pipeline, NDA Filed Molecules, 2010
Table 48: Global Contraceptives Market, Major M&A Deals, 2008-2010
Table 49: Global Contraceptives Market, Licensing Agreements for Drugs in the Phase I, 2008-2010
Table 50: Global Contraceptives Market, Licensing Agreements for Drugs in the Phase II, 2008-2010
Table 51: Global Contraceptives Market, Licensing Agreements for Drugs in the Phase III, 2008-2010
Table 52: Global Contraceptives Market, Licensing Agreements for Marketed Drugs, 2008-2010

List of Chart


Figure 1: Global Contraceptive Market, Drivers and Barriers, 2009 11
Figure 2: Global Contraceptives Market, Revenue Forecasts ($bn), 2001-2016 12
Figure 3: Global Contraceptives Market, Annual Cost of Treatment ($), 2001-2016 13
Figure 4: Global Contraceptives Market, Treatment Usage Patterns (000s), 2001-2016 14
Figure 5: Global Contraceptives Market, Target Population (000s), 2001-2016 16
Figure 6: Global Contraceptives Market, Treatment Seeking Population (000s), 2001-2016 17
Figure 7: Global Contraceptives Market, Population Taking Prescribed Drugs (000s), 2001-2016 18
Figure 8: Global Contraceptives Market, Population Taking OTC Drugs (000s), 2001-2016 19
Figure 9: The US Contraceptives Market, Revenue Forecasts ($bn), 2001-2016 20
Figure 10: The US Contraceptives Market, Annual Cost of Treatment ($), 2001-2016 22
Figure 11: The US Contraceptives Market, Treatment Usage Patterns (000s), 2001-2016 23
Figure 12: The US Contraceptives Market, Target Population (000s), 2001-2016 25
Figure 13: The US Contraceptives Market, Treatment Seeking Population (000s), 2001-2016 26
Figure 14: The US Contraceptives Market, Population Taking Prescribed Drugs (000s), 2001-2016 27
Figure 15: The US Contraceptives Market, Population Taking OTC Drugs (000s), 2001-2016 28
Figure 16: Top Five Countries of Europe Contraceptives Market, Revenue Forecasts ($m), 2001-2016 29
Figure 17: Top Five Countries of Europe Contraceptives Market, Annual Cost of Treatment ($), 2001-2016 30
Figure 18: Top Five Countries of Europe Contraceptives Market, Treatment Usage Patterns (000s), 2001-2016 31
Figure 19: Top Five Countries of Europe Contraceptives Market , Target Population (000s), 2001-2016 33
Figure 20: Top Five Countries of Europe Contraceptives Market, Treatment Seeking Population (000s), 2001-2016 34
Figure 21: Top Five Countries of Europe Contraceptives Market, Population Taking Prescribed Drugs (000s), 2001-2016 35
Figure 22: Top Five Countries of Europe Contraceptives Market, Population Taking OTC Drugs (000s), 2001-2016 36
Figure 23: Japan Contraceptives Market, Revenue ($m), 2001-2016 37
Figure 24: Japan Contraceptives Market, Annual Cost of Treatment ($), 2001-2016 38
Figure 25: Japan Contraceptives Market, Treatment Usage Patterns (000s), 2001-2016 39
Figure 26: Japan Contraceptives Market, Target Population (000s), 2001-2016 41
Figure 27: Japan Contraceptives Market, Treatment Seeking Population (000s), 2001-2016 42
Figure 28: Japan Contraceptives Market, Population Taking Prescribed Drugs (000s), 2001-2016 43
Figure 29: Japan Contraceptives Market, Population Taking OTC Drugs (000s), 2001-2016 44
Figure 30: Global Oral Contraceptives Market, Revenue Forecasts ($bn), 2001-2016 45
Figure 31: Global Oral Contraceptives Market, Annual Cost of Treatment ($), 2001-2016 46
Figure 32: Global Oral Contraceptives Market, Treatment Usage Patterns (000s), 2001-2016 47
Figure 33: Global Oral Contraceptives Market, Target Population (000s), 2001-2016 49
Figure 34: Global Oral Contraceptives Market, Treatment Seeking Population (000s), 2001-2016 50
Figure 35: Global Oral Contraceptives Market, Population Taking Prescribed Drugs (000s), 2001-2016 51
Figure 36: Global Oral Contraceptives Market, Population Taking OTC Drugs (000s), 2001-2016 52
Figure 37: Global Injectables Market, Revenue Forecasts ($m), 2001-2016 53
Figure 38: Global Injectables Market, Annual Cost of Treatment ($), 2001-2016 54
Figure 39: Global Injectables Market, Treatment Usage Patterns (000s), 2001-2016 55
Figure 40: Global Injectables Market, Target Population (000s), 2001-2016 57
Figure 41: Global Injectables Market, Treatment Seeking Population (000s), 2001-2016 58
Figure 42: Global Injectables Market, Population Taking Prescribed Drugs (000s), 2001-2016 59
Figure 43: Global Injectables Market, Population Taking OTC Drugs (000s), 2001-2016 60
Figure 44: Global Topical Contraceptives Market, Revenue Forecasts ($m), 2001-2016 61
Figure 45: Global Topical Contraceptives Market, Annual Cost of Treatment ($), 2001-2016 62
Figure 46: Global Topical Contraceptives Market, Treatment Usage Patterns (000s), 2001-2016 63
Figure 47: Global Topical Contraceptives Market, Target Population (000s), 2001-2016 65
Figure 48: Global Topical Contraceptives Market, Treatment Seeking Population (000s), 2001-2016 66
Figure 49: Global Topical Contraceptives Market, Population Taking Prescribed Drugs (000s), 2001-2016 67
Figure 50: Global Topical Contraceptives Market, Population Taking OTC Drugs (000s), 2001-2016 68
Figure 51: Global Contraceptives Market, R&D Pipeline by Phase (%), 2010 69
Figure 52: Global Contraceptives Market, Competitive Landscape, 2009 74
Figure 53: Global Contraceptives Market, Market Share Analysis, 2009 75
Figure 54: Global Contraceptives Market, Top Companies Sales ($m) , 2009 76
Figure 55: SWOT Analysis-Pfizer 78
Figure 56: SWOT Analysis-Watson Pharmaceuticals 79
Figure 57: SWOT Analysis-Teva Pharmaceuticals 81
Figure 58: SWOT Analysis-Warner Chilcott Pharmaceuticals 82
Figure 59: SWOT Analysis-Johnson & Johnson 84
Figure 60: SWOT Analysis-Bayer Pharmaceuticals 85
Figure 61: Global Contraceptives Market, Major M&A Deals By Value, 2008-2010 87
Figure 62: Global Contraceptives Market, Major Licensing Agreements By Each Phase, 2008-2010 89
Figure 63: Global Contraceptives Market, Major Licensing Agreements By Geography, 2008-2010 90
Figure 64: GBI Research Market Forecasting Model 96

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *